Minnesota HF743 prohibits health plans from using step therapy protocols for prescription insulin drugs.
Minnesota HF743 amends state law to prohibit health plans from using step therapy protocols for prescription insulin drugs. Step therapy protocols require patients to try other drugs before using the prescribed insulin. The bill applies to health plans offered, issued, or renewed on or after January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.